Carolina Muñoz‐Novas

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

Carolina Muñoz‐Novas, María Poza-Santaella, Isabel González-Gascón-y-Marín et al. · BioMed Research International · 2018 · 23 citations · Full text

COVID‐19 in patients with hematological malignancies: A retrospective case series

María Stefanía Infante, Isabel González-Gascón-y-Marín, Carolina Muñoz‐Novas et al. · International Journal of Laboratory Hematology · 2020 · 21 citations · Full text

Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine

Elena Landete, Isabel Gómez-Fernández, Isabel González-Gascón-y-Marín et al. · Human Vaccines & Immunotherapeutics · 2021 · 13 citations · Full text

Immunology, Pathology, Immunotherapy +20

Blood transfusion activity in a general hospital during the COVID‐19 pandemic

K. Marín-Mori, Isabel González-Gascón-y-Marín, María Ángeles Foncillas et al. · Vox Sanguinis · 2020 · 12 citations

Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?

Isabel González-Gascón-y-Marín, Carolina Muñoz‐Novas, Íñigo Rúa‐Figueroa et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 11 citations

Hematological Malignancy, Lymphoid Neoplasia, Predict Clinical Evolution +12